Status:
COMPLETED
The Sponsor Assigns Test Products to Six Skin Areas According to a Concealed Randomization Schedule; Neither the Evaluating Physicians Nor the Participants Know Which Product is Applied to Which Site, Preventing Bias.
Lead Sponsor:
BEIJING YUANBEN INFORMATION CONSULTING CO., LTD
Conditions:
No Protrusion
No Open Wound
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
This is a single-center, double-blind, randomized, and controlled study. The sponsor keeps the allocation of products to the six test sites confidential. Neither the evaluating physicians nor the part...
Eligibility Criteria
Inclusion
- \- 1) Chinese physically healthy female participants, aged between 18 and 65 years old; 2) All skin types (including dry, normal, oily, and combination); 3) Have no significant skin defects, scars, tattoos, protrusions, open wounds, or other factors that would affect the evaluation on the inner side of the forearm skin; 4) Have no severe allergic reactions to the testing reagents containing dansyl chloride; 5) Agree to avoid swimming, prolonged sun exposure, sauna, and steam baths during the study period; 6) Agree to discontinue the use of any other cleansing and skincare products on the forearm during the study period; 7) Willingness to read, write and sign an informed consent form to demonstrate willingness and ability to participate; 8) Willingness to comply with all requirements of the research protocol; 9) Have no reason assessed by the investigators as unsuitable for participation in the testing; 10) Intends to complete the study and is willing and able to follow all study instructions.
- 11\) Subjects who could comply with standards during the whole study that refrain from the use of towel, bath ball or any other bath sponges on the forearm.
Exclusion
- 1\) Undergoing dermatological treatment or those who have taken whitening or anti-aging dietary supplements within the past month; 2) Have allergies to skincare products, soap, alcohol, fragrances, or medications; 3) Have used antihistamines within the past week or immunosuppressants within the past month; 4) Have applied any anti-inflammatory drugs to the test area within the past two months; 5) Have skin conditions such as psoriasis, eczema, dermatitis, skin cancer, etc.; 6) Insulin-dependent diabetes patients; 7) Undergoing treatment for asthma or other chronic respiratory diseases; 8) Have received cancer chemotherapy within the past 6 months; 9) With immunodeficiency or autoimmune diseases; 10) Breastfeeding or pregnant women; 11) Have undergone bilateral mastectomy and bilateral axillary lymph node dissection; 12) With facial erythema, follicular papules, sunspots, wounds, abrasions, tattoos, acne, or any other conditions that may affect the evaluation of test results; 13) With high sensitivity; 14) Have participated in intense outdoor activities or travel that may cause skin damage due to sun exposure within the month prior to the test; 15) Concurrently participating in another clinical trial or who have participated in a facial clinical trial within the past three months; 16) Have applied vitamin A analogues, alpha-hydroxy acids, salicylic acid, hydroquinone, or prescription drugs (antibiotics, vitamin A analogues, alpha-hydroxy acids, and corticosteroids) within the past six months, or oral contraceptives (continuation is allowed if the same contraceptive has been used consistently for the past six months); 17) PI or experts who believe that there are other medical reasons that may affect the test results.
Key Trial Info
Start Date :
December 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07154004
Start Date
December 21 2024
End Date
May 31 2025
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Yuanben Information Consulting Co., Ltd
Beijing, China